Document excerpt filed by Aderis Pharmaceuticals INC. filling Dr. Gevork Minaskanian as the Vice President of Synthetic Chemistry at Aderis (excerpt from a S-1/A SEC Filin)
uspto.gov
patft.uspto.gov
US Patent 5,470,848 Dr. Minaskanian's latest patents related to the subject of transdermal delivery systems from 1995 (US Patent 5,470,848)
Dr. Minaskanian's older US patents related to the subject of transdermal delivery systems from 1989 (US Patent 4,801,586)
Another US Patent that Dr. Minaskanian has related to Neupro (US Patent 5,234,959)
Another US Patent that Dr. Minaskanian has related to Neupro (US Patent 5,118,676)
US Patent 7,309,497 containing a list of some of Dr. Minaskanian's work used by Schwarz Pharma AG to do newer research (US Patent 7,309,497 7)
VCU Department of Chemistry recognizing Dr. Minaskanian research work on rotigotine and Neupro as an unprecedented medication for the benefit of millions of Parkinson’s patients worldwide (VCU Department of Chemistry)
